Trials / Completed
CompletedNCT05302687
Probiotic Modulates Vaginal Microflora
Use of Probiotic to Modulate Vaginal Microflora and General Women's Health
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Min-Tze LIONG · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effects of oral administration of probiotic at 9 log colony forming unit (CFU)/day on vaginal microbiota profiles compared to placebo via the use of vaginal self-swab microbiota profiling.
Detailed description
1. To evaluate differences in general women's health of women on probiotic and placebo via the use of questionnaire. 2. To evaluate differences in immunity of women on probiotic and placebo via blood immunity profiling. 3. To evaluate differences in gut microbiota profiles of women on probiotic and placebo via blood fecal microbiota profiling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | This project aims to evaluate differences in general women's health of women on probiotic and placebo via the use of questionnaire and evaluate differences in immunity of women on probiotic and placebo via blood immunity profiling. To evaluate differences in gut microbiota profiles of women on probiotic and placebo via blood fecal microbiota profiling. |
| DIETARY_SUPPLEMENT | placebo | This project aims to evaluate differences in general women's health of women on probiotic and placebo via the use of questionnaire and evaluate differences in immunity of women on probiotic and placebo via blood immunity profiling. To evaluate differences in gut microbiota profiles of women on probiotic and placebo via blood fecal microbiota profiling. |
Timeline
- Start date
- 2022-01-15
- Primary completion
- 2024-03-18
- Completion
- 2024-03-18
- First posted
- 2022-03-31
- Last updated
- 2024-06-21
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT05302687. Inclusion in this directory is not an endorsement.